Following initiation of treatment, pgRNA declined more in individuals treated with TDF versus ADV at weeks 12 (0.24 log 10 U/mL) and 48 (0.30 log 10 U/mL), although this failed to reach statistical significance.
← all excerpts
Diagnostic Utility of Pre-Genomic Hepatitis B RNA in the Evaluation of HBV/HIV Coinfection.
1
—
—